David S. Tierney - 21 Aug 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ David S. Tierney
Issuer symbol
CPRX
Transactions as of
21 Aug 2024
Net transactions value
-$241,305
Form type
4
Filing time
23 Aug 2024, 17:00:13 UTC
Previous filing
10 Apr 2024
Next filing
25 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $60,150 +15,000 +4.3% $4.01 363,874 21 Aug 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $301,455 -15,000 -4.1% $20.10 348,874 21 Aug 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 +15,000 +8.6% $0.000000 188,931 22 Aug 2024 Common Stock 15,000 $4.01 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $20.00 to $20.485 per share.
F3 Options vested in three annual tranches beginning on January 2, 2019.